Source: Annual Congress 2003 - Asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bacci, M. Zingoni, S. Cianchetti, M. L. Bartoli, F. L. Dente, A. DiFranco, B. Vagaggini, A. DiPaco, P. Paggiaro (Pisa, Italy). Ageing and disease duration may explain low sputum eosinophils in untreated moderate asthmatics. Eur Respir J 2003; 22: Suppl. 45, 3026

Member's Comments

No comment yet.

Related content which might interest you: Eosinophilic inflammation in sputum of poorly controlled asthmatics Source: Eur Respir J 2002; 20: 1370-1377 Year: 2002 Sputum eosinophil percentages during a moderate exacerbation of asthma and during a natural cold Source: Eur Respir J 2002; 20: Suppl. 38, 508s Year: 2002 Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO. Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006 Blood eosinophil in smokers and mild and moderate COPD patients Source: International Congress 2017 – Latest insights into the management of chronic lung diseases Year: 2017 Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Can blood eosinophils predict sputum eosinophils in stable COPD? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Reduced eosinophil apoptosis in induced sputum correlates with asthma severity Source: Eur Respir J 2003; 22: 484-490 Year: 2003 High sputum ECP levels detect functional impairment in asthma better than sputum eosinophils Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Subjects in a population study with high levels of FENO have associated eosinophil airway inflammation in BAL Source: Eur Respir J 2004; 24: Suppl. 48, 469s Year: 2004 Cellular inflammatory pattern in induced sputum among patients with stable moderate or severe asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Sputum microbiota in moderate versus severe patients with COPD Source: Eur Respir J 2014; 43: 1787-1790 Year: 2014 Evaluation of FeNo measurement as an alternative to sputum eosinophils in a severe asthma population Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Mechanisms of noneosinophilic asthma Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma Source: Eur Respir J 2014; 44: 895-904 Year: 2014 Sputum neutrophilic markers in asthma of varying severity and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 550s Year: 2003 Sputum lymphocytes predict the severity of late asthmatic response in asthma Source: Eur Respir J 2004; 24: Suppl. 48, 227s Year: 2004 A treatment regime based on induced sputum eosinophilia does not result in a reduction in exacerbations in refractory severe asthmatics Source: Annual Congress 2008 - Severe asthma: a heterogeneous clinical entity Year: 2008